Helen Twohig1, Caroline Mitchell2, Christian Mallen3, Adewale Adebajo4, Nigel Mathers5. 1. Academic Unit of Primary Medical Care, University of Sheffield, Sheffield, UK. Electronic address: h.twohig@sheffield.ac.uk. 2. Academic Unit of Primary Medical Care, University of Sheffield, Sheffield, UK. Electronic address: c.mitchell@sheffield.ac.uk. 3. Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire, UK. Electronic address: c.d.mallen@keele.ac.uk. 4. Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. Electronic address: a.o.adebajo@sheffield.ac.uk. 5. Academic Unit of Primary Medical Care, University of Sheffield, Sheffield, UK. Electronic address: n.mathers@sheffield.ac.uk.
Abstract
OBJECTIVES: To explore patient experiences of living with, and receiving treatment for, PMR. METHODS: Semi-structured qualitative interviews, with 22 patients with PMR recruited from general practices in South Yorkshire. Thematic analysis using a constant comparative method, ran concurrently with the interviews and was used to derive a conceptual framework. RESULTS: 5 Key themes emerged highlighting the importance of: (1) pain, stiffness and weakness, (2) disability, (3) treatment and disease course, (4) experience of care, (5) psychological impact of PMR. Patients emphasised the profound disability experienced that was often associated with fear and vulnerability, highlighting how this was often not recognised by health care professionals. Patients' experiences also challenge medical convention, particularly around the concept of 'weakness' as a symptom, the use of morning stiffness as a measure of disease activity and the myth of full resolution of symptoms with steroid treatment. Treatment decisions were complex, with patients balancing glucocorticoid side effects against persistent symptoms. CONCLUSIONS: Patients often described their experience of PMR in terms of disability rather than focussing on localised symptoms. The associated psychological impact was significant. PRACTICE IMPLICATIONS: Recognising this is key to achieving shared understanding, reaching the correct diagnosis promptly, and formulating a patient-centred management plan.
OBJECTIVES: To explore patient experiences of living with, and receiving treatment for, PMR. METHODS: Semi-structured qualitative interviews, with 22 patients with PMR recruited from general practices in South Yorkshire. Thematic analysis using a constant comparative method, ran concurrently with the interviews and was used to derive a conceptual framework. RESULTS: 5 Key themes emerged highlighting the importance of: (1) pain, stiffness and weakness, (2) disability, (3) treatment and disease course, (4) experience of care, (5) psychological impact of PMR. Patients emphasised the profound disability experienced that was often associated with fear and vulnerability, highlighting how this was often not recognised by health care professionals. Patients' experiences also challenge medical convention, particularly around the concept of 'weakness' as a symptom, the use of morning stiffness as a measure of disease activity and the myth of full resolution of symptoms with steroid treatment. Treatment decisions were complex, with patients balancing glucocorticoid side effects against persistent symptoms. CONCLUSIONS:Patients often described their experience of PMR in terms of disability rather than focussing on localised symptoms. The associated psychological impact was significant. PRACTICE IMPLICATIONS: Recognising this is key to achieving shared understanding, reaching the correct diagnosis promptly, and formulating a patient-centred management plan.
Authors: Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta Journal: Nat Rev Rheumatol Date: 2017-09-14 Impact factor: 20.543
Authors: Sara Muller; Samantha L Hider; Balamrit Singh Sokhal; Sarah A Lawton; Toby Helliwell; Christian D Mallen Journal: Rheumatol Adv Pract Date: 2022-05-11
Authors: Sarah L Mackie; Helen Twohig; Lorna M Neill; Eileen Harrison; Beverley Shea; Rachel J Black; Tanaz A Kermani; Peter A Merkel; Christian D Mallen; Frank Buttgereit; Chetan Mukhtyar; Lee S Simon; Catherine L Hill Journal: J Rheumatol Date: 2017-08-01 Impact factor: 4.666
Authors: Serene Z Mirza; Jonathan T L Cheah; Nilasha Ghosh; Joanna C Robson; Catherine L Hill; Jasvinder Singh; Sarah L Mackie; Iris Navarro-Millán; Lee S Simon; Susan M Goodman Journal: J Clin Rheumatol Date: 2021-09-01 Impact factor: 3.517
Authors: Sarah Louise Mackie; Colin Thomas Pease; Eiji Fukuba; Emma Harris; Paul Emery; Richard Hodgson; Jane Freeston; Dennis McGonagle Journal: Ann Rheum Dis Date: 2015-09-16 Impact factor: 19.103
Authors: Jennifer Liddle; Roisin Bartlam; Christian D Mallen; Sarah L Mackie; James A Prior; Toby Helliwell; Jane C Richardson Journal: BMJ Open Date: 2017-08-23 Impact factor: 2.692